Aurora Cannabis faces headwinds as Q4/FY2025 revenues grow but profitability declines due to one-time expenses. Check out why I'm downgrading ACB stock to Buy.

This was the stock's fourth consecutive day of gains.

Aurora Cannabis Q4 sales rose 34% to $63.07 million, led by medical cannabis and plant propagation, despite missing earnings estimates.

Read about Aurora Cannabis Inc (ACB:XNAS) stock and today's latest news and financial updates. ACB - Aurora Cannabis Inc News | Morningstar Morningstar brands and products ...

Get the detailed quarterly/annual income statement for Aurora Cannabis Inc. (ACB). Find out the revenue, expenses and profit or loss over the last fiscal year.

Aurora Cannabis shares tumbled Wednesday as the Canadian cannabis operator said it expects “temporary declines” in its ...

Empowering Canadian innovation—discover, invest, and grow with homegrown tech leaders shaping the future. The 2025 Cantech ...

An Edmonton-based cannabis company is cleaning up a mess left behind by an investing site that erroneously published AI-written reports of non-existent business deals.

Proprietary Genetics to be the Highest Potency Medical Cannabis Products Available on the Market NASDAQ | TSX: ACB EDMONTON, AB, June 24, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ...

Aurora Cannabis (ACB) delivered earnings and revenue surprises of -36.36% and 1.65%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Shares of Aurora Cannabis Inc. ACB rallied 3.95% to $4.47 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.94% to ...